Gera L - Search Results

1

Evidence for bradykinin as a stimulator of thirst.

Cadnapaphornchai MA, Rogachev B, Summer SN, Chen YC, Gera L, Stewart JM, Schrier RW. Cadnapaphornchai MA, et al. Among authors: gera l. Am J Physiol Renal Physiol. 2004 May;286(5):F875-80. doi: 10.1152/ajprenal.00243.2003. Epub 2004 Jan 6. Am J Physiol Renal Physiol. 2004. PMID: 15075183 Free article.

2

A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model.

Taraseviciene-Stewart L, Gera L, Hirth P, Voelkel NF, Tuder RM, Stewart JM. Taraseviciene-Stewart L, et al. Among authors: gera l. Can J Physiol Pharmacol. 2002 Apr;80(4):269-74. doi: 10.1139/y02-047. Can J Physiol Pharmacol. 2002. PMID: 12025960

3

New lung cancer drugs from bradykinin antagonists.

Stewart JM, Gera L, Chan DC, York EJ, Stewart LT, Simkeviciene V, Helfrich B. Stewart JM, et al. Among authors: gera l. Chest. 2004 May;125(5 Suppl):148S. doi: 10.1378/chest.125.5_suppl.148s. Chest. 2004. PMID: 15136471 No abstract available.

4

Pseudopeptide analogs of bradykinin and bradykinin antagonists.

Vavrek RJ, Gera L, Stewart JM. Vavrek RJ, et al. Among authors: gera l. Agents Actions Suppl. 1992;38 ( Pt 1):565-71. doi: 10.1007/978-3-0348-7321-5_69. Agents Actions Suppl. 1992. PMID: 1466297

5

Bradykinin antagonists do not require a D-aromatic amino acid residue at position 7.

Vavrek RJ, Gera L, Stewart JM. Vavrek RJ, et al. Among authors: gera l. Agents Actions Suppl. 1992;38 ( Pt 1):572-81. doi: 10.1007/978-3-0348-7321-5_70. Agents Actions Suppl. 1992. PMID: 1466298

6

A new class of bradykinin antagonists containing indanylglycine.

Gera L, Stewart JM. Gera L, et al. Immunopharmacology. 1996 Jun;33(1-3):174-7. doi: 10.1016/0162-3109(96)00098-7. Immunopharmacology. 1996. PMID: 8856143 No abstract available.

7

Oral activity of peptide bradykinin antagonists following intragastric administration in the rat.

Whalley ET, Hanson WL, Stewart JM, Gera L. Whalley ET, et al. Among authors: gera l. Can J Physiol Pharmacol. 1997 Jun;75(6):629-32. Can J Physiol Pharmacol. 1997. PMID: 9276140

8

Bradykinin antagonists: present progress and future prospects.

Stewart JM, Gera L, York EJ, Chan DC, Bunn P. Stewart JM, et al. Among authors: gera l. Immunopharmacology. 1999 Sep;43(2-3):155-61. doi: 10.1016/s0162-3109(99)00102-2. Immunopharmacology. 1999. PMID: 10596848 Review.

9

Bradykinin-related compounds as new drugs for cancer and inflammation.

Stewart JM, Gera L, Chan DC, Bunn PA Jr, York EJ, Simkeviciene V, Helfrich B. Stewart JM, et al. Among authors: gera l. Can J Physiol Pharmacol. 2002 Apr;80(4):275-80. doi: 10.1139/y02-030. Can J Physiol Pharmacol. 2002. PMID: 12025961

10

Bradykinin antagonists as new drugs for prostate cancer.

Stewart JM, Chan DC, Simkeviciene V, Bunn PA Jr, Helfrich B, York EJ, Taraseviciene-Stewart L, Bironaite D, Gera L. Stewart JM, et al. Among authors: gera l. Int Immunopharmacol. 2002 Dec;2(13-14):1781-6. doi: 10.1016/s1567-5769(02)00181-9. Int Immunopharmacol. 2002. PMID: 12489792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters